Market Research Logo

Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood, Kidney, Prostate, Ovarian And Pancreatic Cancer) And Segment Forecasts, 2014

Cancer Diagnostics Market Analysis By Type (Laboratory Tests, Genetic Tests, Imaging, Endoscopy, Biopsy), By Application (Breast, Lung, Liver, Cervical, Colorectal, Skin, Blood, Kidney, Prostate, Ovarian And Pancreatic Cancer) And Segment Forecasts, 2014 - 2025

The global cancer diagnostics market is expected to reach USD 232.7 billion by 2025, according to a new report by Grand View Research, Inc. Continual introduction of innovative products coupled with increasing need for early diagnosis of the disease is the prime factor driving the market growth.

In addition, rapid growth of the sector is attributed to the penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering the demand for these screening tests and imaging modalities that are used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early diagnosis of the disease. In addition, cancer research organizations along with public and private entities are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease way before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility of their products. For instance, Illumina,Inc. launched a new venture named GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than $100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Further Key Findings from the Study Suggest:

Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of the imaging systems space.

The breast cancer segment, among other application segments, accounted for the largest share due to the high incidence rate of breast cancer triggering the need for its early diagnosis.

In 2015, North America dominated the global space with the largest revenue share of more than 40%.

Focused research efforts in oncology for the development of early tumor detection tools coupled with grants from government healthcare agencies are contributing to a strong medical ecosystem to fight cancer in this region.

Asia Pacific is expected to emerge as the fastest growing region during the forecast period.

The growing patient pool in India, China, and Japan; due to the support in diagnostic process at comparatively lower prices; and a favorable regulatory framework are some of the factors boosting the market growth in this region.

Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd and Siemens Healthcare GmbH.

Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; .and Hologic,Inc.


Chapter 1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Cancer Diagnostics Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.2 Market Driver Analysis
3.2.1 Rising prevalence of cancer cases
3.2.2 Technological advancement
3.2.3 Initiatives undertaken by government and awareness about cancer
3.2.4 Reimbursement coverage
3.3 Market Restraints Analysis
3.3.1 Lack of sensitivity and specificity
3.3.2 Risk of high radiation exposure used in different treatments
3.3.3 Cost of diagnosis
3.3.4 Penetration & growth prospect mapping
3.4 Cancer Diagnostics - SWOT Analysis, By Factor (political & legal, economic and technological)
3.5 Industry Analysis - Porter’s
Chapter 4 Cancer Diagnostics Market : Screening Type Estimates & Trend Analysis
4.1. Cancer Diagnostics Market: Screening Type movement analysis
4.2 Laboratory Tests
4.2.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
4.3 Genetic Tests
4.3.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
4.4 Imaging
4.4.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
4.5 Endoscopy
4.5.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
4.6 Biopsy
4.6.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
4.7 Others (Barium Enema)
4.7.1 Marketestimates and forecast, 2014 - 2025 (USD Billion)
Chapter 5 Cancer Diagnostics Market: Application Estimates & Trend Analysis
5.1 Cancer Diagnostics Market: Application movement analysis
5.2 Breast Cancer
5.2.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.3 Colorectal Cancer
5.3.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.4 Cervical Cancer
5.4.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.5 Lung Cancer
5.5.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.6 Prostate cancer
5.6.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.7 Skin Cancer
5.7.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.8 Blood Cancer
5.8.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.9 Kidney Cancer
5.9.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.10 Liver Cancer
5.10.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.11 Pancreatic Cancer
5.11.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.12 Ovarian Cancer
5.12.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
5.13 Others
5.13.1 Market estimates and forecast, 2014 - 2025 (USD Billion)
Chapter 6 Cancer Diagnostics Market: Regional Estimates & Trend Analysis, by Screening Type & Application Type
6.1 North America
6.1.1 U.S.
6.1.1.1 Market estimates and forecast, by screening type 2014 - 2025 (USD Billion)
6.1.1.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.1.2 Canada
6.1.2.1 Market estimates and forecast, screening type 2014 - 2025 (USD Billion)
6.1.2.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.2 Europe
6.2.1 UK
6.2.1.1 Market estimates and forecast,screening type 2014 - 2025 (USD Billion)
6.2.1.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.2.2 Germany
6.2.2.1 Market estimates and Forecast, screening type 2014 - 2025 (USD Billion)
6.2.2.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.3 Asia Pacific
6.3.1 Japan
6.3.1.1 Market estimates and forecast, screening type 2014 - 2025 (USD Billion)
6.3.1.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.3.2 China
6.3.2.1 Market Estimates and Forecast, screening type 2014 - 2025 (USD Billion)
6.3.2.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.4 Latin America
6.4.1 Brazil
6.4.1.1 Market estimates and forecast, screening type 2014 - 2025 (USD Billion)
6.4.2.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.4.2 Mexico
6.4.2.1 Market estimates and forecast,screening type 2014 - 2025 (USD Billion)
6.4.2.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
6.5 Middle East and Africa (MEA)
6.5.1 South Africa
6.5.1.1 Market estimates and forecast, screening type 2014 - 2025 (USD Billion)
6.5.1.2 Market estimates and forecast, by application, 2014 - 2025 (USD Billion)
Chapter 7 Competitive Landscape
7.1 Abbott
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Qiagen
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Siemens Healthcare GmbH
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.4.4 Strategic Initiatives
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 GE Healthcare
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Hologic,Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
7.7.4 Strategic Initiatives
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Product Benchmarking
7.8.4 Strategic Initiatives
7.9 Koninklijke Philips N.V.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Product Benchmarking
7.9.4 Strategic Initiatives
7.10 Illumina, Inc.
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Product Benchmarking
7.10.4 Strategic Initiatives
List of Tables
TABLE 1 North America Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 2 North America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 3 U.S. Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 4 U.S. Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 5 Canada Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 6 Canada Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 7 Europe Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 8 Europe Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 9 UK Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 10 UK Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 11 Germany Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 12 Germany Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 13 Asia Pacific Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 14 Asia Pacific Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 15 Japan Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USDBillion)
TABLE 16 Japan Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 17 China Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 18 China Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 19 Latin America Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 20 Latin America Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 21 Brazil Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USDBillion)
TABLE 22 Brazil Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 23 Mexico Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 24 Mexico Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 25 MEA Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 26 MEA Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
TABLE 27 South Africa Cancer Diagnostics Market, By Diagnostics type, 2014 - 2025 (USD Billion)
TABLE 28 South Africa Cancer Diagnostics, By Application, 2014 - 2025 (USD Billion)
List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Penetration & Growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Cancer Diagnostics Market product outlook key takeaways
FIG. 16 Cancer Diagnostics: Screening Type movement analysis
FIG. 17 Laboratory Tests Market, 2014 - 2025 (USDBillion)
FIG. 18 Genetic Tests Market, 2014 - 2025 (USD Billion)
FIG. 19 Imaging Market, 2014 - 2025 (USD Billion)
FIG. 20 Endoscopy Market, 2014 - 2025 (USD Billion)
FIG. 21 BiopsyMarket, 2014 - 2025 (USD Billion
FIG. 22 Others Market, 2014 - 2025 (USDBillion)
FIG. 23 Cancer Diagnostics market Application outlook key takeaways
FIG. 24 Cancer Diagnostics : Application movement analysis
FIG. 25 Breast Cancer Market, 2014 - 2025 (USD Billion)
FIG. 26 Colorectal Cancer Market, 2014 - 2025 (USD Billion)
FIG. 27 Cervical Cancer Market, 2014 - 2025 (USD Billion)
FIG. 28 Lung Cancer Market, 2014 - 2025 (USD Billion)
FIG. 29 Prostate Cancer Market, 2014 - 2025 (USD Billion)
FIG. 30 Skin Cancer Market, 2014 - 2025 (USDBillion)
FIG. 31 Blood Cancer Market, 2014 - 2025 (USDBillion)
FIG. 32 Kidney Cancer Market, 2014 - 2025 (USD Billion)
FIG. 33 Liver Cancer Market, 2014 - 2025 (USD Billion)
FIG. 34 Pancreatic Cancer Market, 2014 - 2025 (USD Billion)
FIG. 35 Ovarian Cancer Market, 2014 - 2025 (USD Billion)
FIG. 36 Others Market, 2014 - 2025 (USD Billion)
FIG. 37 Regional market place: Key takeaways
FIG. 38 Strategy framework
FIG. 39 Participant categorization

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report